Abstract
The cataleptogenic effects of the selective D1 dopamine receptor antagonist, SCH 23390, and the selective D2 dopamine receptor antagonist, raclopride, when administered alone or in combination were studied in rats using the vertical grid and horizontal bar methods. In either model both agents, given alone, produced dose-dependent catalepsy. When administered together, there was a marked synergy between the two drugs. Thus, a low dose of SCH 23390 resulted in a 10-fold shift to the left of the raclopride dose-effect curve. When the same low dose of SCH 23390 was administered together with a subcataleptogenic dose of raclopride, marked catalepsy was produced. The finding of synergy between selective D1 and D2 dopamine antagonists in the induction of catalepsy suggests that mixed antagonists may possess greater antipsychotic activity than neuroleptics acting mainly on one receptor subtype.
References
Jan 1, 1975·Pharmacology, Biochemistry, and Behavior·J MajB Przewlocka
Nov 5, 1985·European Journal of Pharmacology·M Morelli, G Di Chiara
Dec 1, 1985·Pharmacology, Biochemistry, and Behavior·W R Klemm
Apr 9, 1986·European Journal of Pharmacology·P BaroneT N Chase
Apr 27, 1988·European Journal of Pharmacology·G H Fletcher, M S Starr
Jan 1, 1986·Psychopharmacology·S O OgrenS E Sjöstrand
Mar 10, 1988·Neuroscience Letters·S O Ogren, K Fuxe
May 13, 1985·Life Sciences·E MellerM Goldstein
Apr 16, 1984·Life Sciences·A V ChristensenO Svendsen
Jan 1, 1983·Annual Review of Neuroscience·I CreeseS E Leff
Apr 3, 1980·Nature·P R Sanberg
Citations
Jan 1, 1997·Journal of Neural Transmission·A R BraunM M Mouradian
Jan 1, 1990·Psychopharmacology·S A ParashosT N Chase
Mar 1, 1996·Psychopharmacology·B J Kinon, J A Lieberman
Mar 1, 1995·Psychopharmacology·T M HydeJ E Kleinman
Jan 1, 1996·Psychopharmacology·C MarinT N Chase
Apr 1, 1996·Biulleten' eksperimental'noĭ biologii i meditsiny·R R Gaĭnetdinov, K S Raevskiĭ
Feb 9, 1993·European Journal of Pharmacology·E P PrinssenA R Cools
Mar 2, 1993·European Journal of Pharmacology·S M PapaT N Chase
May 1, 1993·Neuropharmacology·K YoshidaA Horita
Jun 1, 1995·Neuropharmacology·C Marin, T N Chase
Jun 1, 1991·Pharmacology, Biochemistry, and Behavior·A Horita, M A Carino
May 1, 1993·Pharmacology, Biochemistry, and Behavior·C MarinT N Chase
Feb 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·R R GainetdinovK S Rayevsky
Jul 16, 2003·European Journal of Pharmacology·Satoru NakaiTetsuro Kikuchi
Mar 18, 2000·European Journal of Pharmacology·D BoulayG Perrault
May 10, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Renata C DutraMaria A B F Vital
Oct 17, 1998·Progress in Neurobiology·W Hauber
Aug 6, 1998·Neuroscience·W HauberM Münkle
Aug 15, 1995·Biological Psychiatry·B K LipskaD R Weinberger
Nov 19, 2011·The International Journal of Neuropsychopharmacology·Tomek J Banasikowski, Richard J Beninger
Jan 1, 1991·Life Sciences·A HoritaY Nishimura
Oct 1, 1992·Synapse·R E SeeC K Meshul